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Abstract
Background: Babesia are emerging health threats to humans and animals in the United States. A collaborative
effort of multiple disciplines to attain optimal health for people, animals and our environment, otherwise known as
the One Health concept, was taken during a research workshop held in April 2009 to identify gaps in scientific
knowledge regarding babesioses. The impetus for this analysis was the increased risk for outbreaks of bovine
babesiosis, also known as Texas cattle fever, associated with the re-infestation of the U.S. by cattle fever ticks.
Results: The involvement of wildlife in the ecology of cattle fever ticks jeopardizes the ability of state and federal
agencies to keep the national herd free of Texas cattle fever. Similarly, there has been a progressive increase in the
number of cases of human babesiosis over the past 25 years due to an increase in the white-tailed deer
population. Human babesiosis due to cattle-associated Babesia divergens and Babesia divergens-like organisms have
begun to appear in residents of the United States. Research needs for human and bovine babesioses were
identified and are presented herein.
Conclusions: The translation of this research is expected to provide veterinary and public health systems with the
tools to mitigate the impact of bovine and human babesioses. However, economic, political, and social
commitments are urgently required, including increased national funding for animal and human Babesia research,
to prevent the re-establishment of cattle fever ticks and the increasing problem of human babesiosis in the United
States.
Background
Babesioses are emerging tick-borne diseases in humans
and animals caused by the intraerythrocytic apicom-
plexan protozoa Babesia spp [1]. More than 100 species
of Babesia have been described, several remain to be
fully described, and it is likely that many more species
remain to be discovered [2]. While ticks are second only
to mosquitoes as worldwide vectors of human diseases,
they are the most relevant vectors of disease-causing
pathogens in domestic and wild animals [3]. Climate,
host movement, animal husbandry practices, vector dis-
tribution and vector population changes affect the epi-
demiology of babesioses and other tick-borne diseases.
Changes in these factors could result in enhanced Babe-
sia transmission across vertebrate species by infected
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tick vector populations [4].
The One Health concept, which is used here to define
the collaborative effort of multiple disciplines to attain
optimal health for people, animals and our environment,
was applied to a workshop organized to identify gaps in
the scientific knowledge regarding bovine and human
babesioses in the United States [5]. Emphasis was placed
on the potential threat of reintroduction of cattle fever
ticks (CFT) into the U.S. and concomitant increase in
the risk for outbreaks of bovine babesiosis, but we also
addressed the emerging problem of human babesiosis
because collaboration between entomologist, epidemiol-
ogists, physicians, veterinarians, and related health-
sciences experts can most effectively address these clo-
sely related health issues.
Discussions by the workshop participants focused on
(I) epidemiology and surveillance, (II) ecology and biol-
ogy of tick vectors and wildlife, (III) diagnosis, treat-
ment, and prevention, (IV) integrated approaches for
sustainable CFT eradication, and (V) tick vaccines in the
context of bovine and human babesioses. Here, we pre-
sent a list of research needs for bovine and human
babesioses as the outcome of the workshop exercise.
The translation of this research is expected to provide
veterinary and public health systems with the tools to
mitigate the impact of tick-borne babesioses.
Bovine babesiosis
Bovine, canine, and equine babesioses are among the
most economically relevant infections of domestic ani-
mals. Infestations with CFT, Rhipicephalus (Boophilus)
microplus and R.( B.)annulatus, economically impact
cattle production in tropical and subtropical regions of
the world. They cause damage directly by reducing
weight gain and milk production and are vectors of
pathogens that cause bovine babesiosis (Babesia bovis
and B. bigemina), also known as cattle tick fever or
Texas cattle fever, and the etiologic agent of anaplasmo-
sis (Anaplasma marginale) [4,6,7]. The U.S. Cattle Fever
Tick Eradication Program (CFTEP) was initiated in 1906
to free the national cattle herd from bovine babesiosis
[8]. Subsequently, CFT were officially eradicated from
the U.S. in 1943 with the exception of a permanent
quarantine zone that remains in place today in South
Texas along the border with Mexico. It is estimated that
the livestock industry realizes annual savings of at least
3 billion dollars at today’sc u r r e n c yr a t es i n c et h eU . S .
was declared free of CFT and bovine babesiosis [8].
However, the apparent re-infestation of the U.S. by
CFT, which is thought to be due primarily to changes
affecting the ecology of ticks and wild ungulate hosts
that may support the maintenance and dissemination of
CFT, is impacting the ability of state and federal
agencies to keep the national herd free of CFT and con-
sequently bovine babesiosis.
Epidemiology and surveillance
The number of CFT outbreaks within and outside the
permanent quarantine zone fluctuates with time (Fig. 1).
A significant incursion of CFT took place in the 1970s.
From a total of 170 outbreaks recorded in 1973, 112
occurred outside of the permanent quarantine zone. It
took six years to re-eradicate the ticks at a significant
cost to producers and agencies with mandated control
responsibilities. During the last five years, the level of
CFT activity in the U.S. has once again increased sub-
stantially. The largest number of infested premises in
the permanent quarantine zone was initially recorded in
2005, but that record was broken again in 2008 when
CFT were detected in 85 premises. A sustained spillover
of CFT into the free zone also has been noted since
2004. There appears to be a spike in the number of out-
breaks in the permanent quarantine zone prior to the
explosion of outbreaks in the free zone that was
recorded in 1973 (Fig. 1). Not only do we see a similar
pattern now, but also the development of outbreaks in
the permanent quarantine zone suggests that the num-
ber and extent of outbreaks in the free zone may con-
tinue to increase (Fig. 1). This situation is indeed an
emergency that requires both immediate and long-term
interventions.
Surveillance is critical to determine if changes in
environmental factors are affecting tick populations and/
or pathogen transmission dynamics [9]. Regulations for
CFT surveillance are established and applied to domes-
tic cattle populations. Current surveillance for CFT is
designed for detection of infestations on cattle moved
into the U.S. But, the landscape in South Texas has
changed considerably in the recent past. For example,
the number of non-traditional farms and properties
maintained exclusively for hunting has increased sub-
stantially. These factors, combined with the increased
densities of native (i.e. white-tailed deer), and non-native
(exotic) ungulate species, have complicated surveillance.
White-tailed deer and exotic ungulate species may sup-
port CFT populations in the absence of cattle, and this
may add a new dimension to tick population dynamics
in this region. However, adequate surveillance tools and
methodologies have not been developed for native and
exotic ungulate species. The lack of sufficient surveil-
lance tools for detection of CFT on alternative hosts in
the absence of cattle is urgently needed to maintain a
successful eradication program.
Ecology and biology of tick vectors and wildlife
Native and non-native species of wild ungulates, particu-
larly white-tailed deer, are a major complicating factor
Pérez de León et al. Parasites & Vectors 2010, 3:36
http://www.parasitesandvectors.com/content/3/1/36
Page 2 of 11in CFT eradication efforts. CFT eradication in pastures
vacated of cattle was considered impossible as long as
white-tailed deer remained within an area [10]. Approxi-
mately 20,000 white-tailed deer had to be culled (Hour-
rigan, unpublished data) before CFT eradication in
Florida was officially completed in 1961 [11]. The suit-
ability of cervid and non-domestic bovid species as
hosts for CFT is well documented [12-15]. In South
Texas, complexities of the expanding infestations are
compounded by agricultural practices, as well as recrea-
tional, environmental and ecological conditions promot-
ing an abundance of white-tailed deer and non-native
wild ungulates. Hunter-killed wildlife surveillance in
Zapata and Starr Counties revealed that during fiscal
year 2009 at least 30% of all the CFT infestations in the
permanent quarantine zone occurred in white-tailed
deer. Additionally, Cantu et al. [16,17] documented the
exposure of white-tailed deer to B.bovis and B.bigemina.
These findings highlight the need to understand risks to
cattle populations from CFT infestations and Babesia
infection in native and non-native ungulate populations.
To date, only one non-native ungulate species, the nil-
gai antelope (Boselaphus tragocamelus), has been evalu-
ated for host suitability [14]. Non-native ungulate
populations have expanded considerably in Texas and
other states over the last 30 years. Texas is estimated to
have more than 70 species of non-native ungulates,
numbering over 200,000 animals [18]. Incomplete fen-
cing and poor maintenance of high fences has allowed
many animals to escape, and at least five species of exo-
tic ungulates exist as free ranging populations in Texas
and other regions of the U.S. where they are commonly
farmed or have been intentionally released [18-26].
These animals pose a continued risk for maintaining
and disseminating CFT populations.
Some species of non-native wild ungulates may also
contribute to the re-establishment of CFT infestations
and Texas cattle fever. Two separate efforts conducted
Figure 1 Historical record of cattle fever tick outbreaks in the United States. *Each fiscal year shows the contribution by the Permanent
Quarantine and Free zones to the total number of outbreaks. The Free Zone comprises the area in the forty-eight contiguous states outside the
Permanent Quarantine Zone, which is located along the Rio Grande River in southern Texas. The period shown in the graph depicts records
maintained by APHIS-VS and it covers fiscal years 1960 through 2009. Data updated after [59].
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Page 3 of 11in 2009 confirmed that a herd of nilgai antelope in
Cameron County, Texas was infested with CFT. Addi-
tionally, nilgai were reported to be susceptible to infec-
tion with Babesia spp. in India [27].
The roles that white-tailed deer and non-native ungu-
late species play in the dissemination of CFT across the
landscape are poorly understood. In addition, it is
unclear how this potential dissemination of CFT may be
linked to current and past infestations of cattle.
A small number of studies have been published on
cattle-CFT interactions during the blood-feeding process
[28,29]. Results from these studies will advance our
understanding of the immunological basis for innate
and acquired resistance to CFT in cattle. However, the
molecular basis and effects on host defense mechanisms
of bioactive factors in the saliva of CFT remains largely
unexplored. Much work needs to be done to provide
the foundation for development of novel control strate-
gies for disease prevention.
Diagnosis, treatment, and prevention
Various assays have been developed and used for diag-
nostic purposes in research on Texas cattle fever
[30,31]. Complement fixation, indirect fluorescent anti-
body and polymerase chain reaction tests are adequate
for early detection and can be used for long-term car-
riers. Competitive ELISA yields positive results, but this
technological platform is not currently commercially
available [30,31]. Cattle imported from Mexico are not
tested for Babesia because the tick vector had been con-
tained within the permanent quarantine zone and cur-
rent CFT eradication measures appear to have
prevented outbreaks of clinical Texas cattle fever. How-
ever, the emerging re-infestation by CFT increases the
risk for the re-emergence of Texas cattle fever in the
U.S. CFT eradication achieved since 1943 also obviated
the need to use babesiacidal drugs in cattle. Thus, there
is no drug registered in the U.S. to treat bovine babesio-
sis. The risk is amplified further by the suspected ability
of wildlife to serve as competent reservoirs for B.bovis
and B. bigemina [17,27].
Tick “scratching” is the method approved to detect and
identify CFT infestations in cattle and deer. However, lar-
vae infesting animals can readily escape human detection.
Serologic tests and other sensing technologies should be
explored for their utility to test cattle and wildlife for
CFT infestation. For example, antibodies to unique sali-
vary proteins in other tick vectors can be detected by
ELISA [32]. This technique may allow larval detection
and an ELISA test would be amenable to standardization.
However, tick “scratching” yields immediate results on
site, while an ELISA would require dedicated equipment
and results take longer to develop. In addition, serologic
assays might not be able to distinguish between current
and previous infestations. Increased efficiency for CFT
detection may be achieved through the combination of
different methods. “Scratching” of live white-tailed and
other wildlife is more problematic. This is especially chal-
lenging in areas devoid of cattle that are adjacent to quar-
antined premises. The challenge is complicated further
by the lack of a sentinel system for the presence of CFT
in the landscape when the option to vacate cattle from
premises is exercised by the landowner.
Babesia vaccines against B. bovis and B. bigemina con-
sisting of living attenuated parasites are in use in endemic
areas worldwide. However, live Babesia vaccines have a
number of limitations, including short shelf life, possibi-
lity of reversion to virulence, the need of a cold chain,
and the establishment of persisting Babesia infections in
the vaccinated areas. Additionally, vaccination with live
vaccines causes the animals to become seropositive
against Babesia thus making difficult to distinguish vacci-
nated from infected animals upon serological screening,
confounding diagnostic efforts. Ideally vaccines should
overcome these limitations, and preferably be based on
strains that are not transmissible by ticks. In the context
of the current increased risk of a Babesia outbreak that
might cause substantial economic damage, it would be
practical to have both B. bovis and B. bigemina live vac-
cines, or at least vaccine-ready attenuated strains, avail-
able in case urgent preventive measures are required.
However, such vaccines are not licensed for use in the
U.S. currently. Research efforts are currently being direc-
ted towards the use of a novel transfection system to aid
in the development of better defined non tick-transmissi-
ble vaccine strains that may overcome some of the limita-
tions of current vaccines [33]. Together with the
availability of the B. bovis genome [34], Babesia transfec-
tion techniques can be helpful for: (i) helping to define
virulence factors by gene knock-out techniques; (ii) the
production of viable and attenuated Babesia strains that
are deficient in known virulence factors; (iii) introducing
antigenic molecular markers that may help to discrimi-
nate vaccinated from naturally infected animals; (iv) pro-
ducing Babesia strains that express protective tick
antigens, such as Bm86, that may elicit dual protection,
against Babesia disease and tick infestation. Effective sub-
unit vaccines would be ideal for prevention of bovine
babesiosis but no one is yet available [35]. Developing
subunit vaccines will likely require better characterization
of protective immune responses, the host-parasite rela-
tionship, further identification of vaccine candidate anti-
gens, and effective methods of vaccine delivery [35].
Integrated approaches for sustainable cattle fever
tick eradication
Cattle drives in the nineteenth century facilitated the
expansion of CFT populations throughout the U.S [36].
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14 southern states including Missouri, Kentucky and
southern California. In 1868, a major outbreak of cattle
tick fever killed 15,000 cattle in Illinois and Indiana fol-
lowing the importation of apparently healthy cattle from
Texas [37]. Following definitive studies done in colla-
boration with Frederick L. Kilborne which lead to our
understanding of how the disease was transmitted to
cattle by CFT, Theobald Smith stated, “Eliminate the
ticks on cattle and you eradicate the ticks because they
cannot live elsewhere” [38]. That concept is untenable
today despite heroic efforts by Cattle Fever Tick Eradi-
cation Program personnel operating with limited
resources and is inadequate to sustain CFT eradication
in the U.S.
Bovine babesiosis and CFT are endemic in Mexico.
Almost a million cattle are imported annually into the
U.S. from Mexico through Texas. Stray animals, smug-
gling of livestock, free crossing of wildlife across the U.
S. - Mexico border, and pervasive acaricide resistance in
Mexico are major risk factors for re-emergence of CFT
and bovine babesiosis in the U.S. The organophosphate
compound Coumaphos is the only acaricide approved
for official use by the Cattle Fever Tick Eradication Pro-
gram in dipping vats since 1970. Another challenge for
total eradication is that CFT have no natural enemies in
the U.S. since they are an invasive species that was
brought into the country with livestock by European
settlers.
Despite recent technological advancements that fueled
the development and commercialization of vaccines
based on the tick antigen Bm86 in Australia and certain
Latin American countries [39], acaricides remain the
principal means commercially accessible for tick eradica-
tion. However, development and commercialization of
novel acaricides is challenging and costly [40]. This
situation reinforces the need for alternative approaches
to control tick infestations [41,42].
Tick vaccines
Tick vaccines have been developed that induce immuno-
logical protection of vertebrate hosts against tick infesta-
tions. The feasibility of controlling tick infestations
through immunization of hosts with selected tick anti-
gens was demonstrated with the development of vac-
cines based on recombinant Bm86 protein derived from
the gut of Rhipicephalus (Boophilus) s p p .a n du s e dt o
induce a protective immune response that reduced
infestations on cattle [39,41,42]. These products repre-
sent the first generation of tick vaccines to be commer-
cialized. Control of ticks by vaccination has the
advantages of being cost-effective, reducing environmen-
tal contamination and prevention of the selection of
drug resistant ticks that result from repeated acaricide
application. Development of vaccines against ticks
would also allow for inclusion of multiple antigens that
could target a broad range of tick species and may also
prevent pathogen transmission. Vaccines that target tick
saliva molecules essential for successful blood feeding
and pathogen transmission are an active area of
research.
The utility of tick vaccines based on Bm86, used alone
or in combination with acaricides, for eradication
purposes needs to be explored. Gavac® is one of the
Bm86-based tick vaccines, which is registered and com-
mercially available in Mexico, but not in the U.S. Tick
vaccines have to be registered in the U.S. before business
concerns can sell them to producers for use in cattle.
The development of a critical path for registration and
the need for production domestically would need to be
considered if Bm86-based tick vaccines show potential as
a tool for CFT eradication. Assessing this potential
requires the conduct of trials in the U.S. before those
anti-tick vaccines are licensed for use in South Texas.
See Table 1 for list of research needs in bovine
babesiosis.
Human babesiosis
Human babesiosis was first reported in 1957, more than
a half century after the problem of cattle babesiosis was
recognized. Since that time, the epidemiology of human
babesiosis has changed from a few isolated cases in
coastal New England to the recognition of expanding
endemic areas in the northeastern and mid-western
United States and episodic cases reported in Europe,
Asia, Africa and South America [43]. Babesia microti,
the most common Babesia species that causes human
babesiosis, is endemic in much of the Northeast and
northern Midwest and is also the most frequent transfu-
sion transmitted microbial agent in the United States
[44]. Babesiosis is most often a mild to moderate illness
that lasts for about a week. It also may have significant
associated morbidity and a mortality rate that ranges
from 3-5% in previously health people to greater than
20% in immunocompromised hosts [43,45].
Epidemiology and surveillance
Babesiosis is an emerging infection among humans.
There has been a progressive increase in reported cases
each year over the past 25 years in northeastern and
northern mid-western states, including recently
described cattle-associated Babesia divergens and Babe-
sia divergens-like cases [43]. No national reporting
requirement currently exists and the number of actual
cases is thought to be greatly underestimated. Babesia
infection has also been increasingly identified as a cause
of disease in people throughout the world. Severity of
infection ranges from asymptomatic to fulminant disease
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Page 5 of 11Table 1 Research needs for bovine and human babesioses by scientific and technological topic.
Topic Bovine babesiosis Human babesiosis
Epidemiology &
surveillance
Integrate refinement of tick population dynamics models, data
gathering, as well as the knowledge of land use, numbers and
species of Babesia tick vectors and domestic and wildlife hosts
with economic analyses of their relevance in order to facilitate
and enhance decision-making processes for optimal allocation
of resources for regulatory and research programs
Assess current status and forecast future epidemiologic
trends of babesioses in humans and keystone hosts through
the expansion of field data capture methods and through
collaborations between federal and state regulatory
agencies and academic institutions
Refine existing methods and develop new tools for active
surveillance, such as serological tests and alternatives or
refinement to “scratching” (use of inspector’s fingers to feel
the skin of the animal in its entirety, from head to tail,
searching for ticks) of wildlife to evaluate tick exposure, the
detection of Babesia in ticks and hosts, and the control of
cattle movement
Investigate the tick vectors and pathogenesis of babesiosis
caused by B. microti, which is the primary etiologic agent of
human disease
Explore genetic structure of CFT populations across the range
of outbreaks in South Texas to determine tick geographic
origin(s) and population dynamics
Continue studies of Babesia-host interactions for infection in
humans
Determine whether CFT from outbreaks in South Texas are
infected with B. bigemina and/or B. bovis to assess risk
potential for outbreaks of clinical infection in the U.S.
Increase studies of transfusion transmitted babesiosis,
especially regarding prevention
Continue studies of Babesia-host interactions for infection in
cattle and wildlife
Ecology & biology of
tick vectors & wildlife
Evaluate the host suitability of non-native wild ungulates
common to South Texas for CFT
Investigate white-tailed-targeted tick control and white-
tailed deer population management strategies as a means
to decrease the risk for tick-borne babesiosis in humans
Define the ecological role of native and non-native wild
ungulates in maintaining CFT populations in the absence of
cattle
Conduct ecological studies to determine whether native and
non-native wild ungulates play a role in the long term
maintenance and dissemination of CFT populations,
particularly between infested and tick-free areas
Characterize molecular and cellular interactions at the host-
blood feeding tick interface for bovine and non-bovine hosts
Conduct immunological studies to simultaneously characterize
and correlate R. microplus and R. annulatus salivary gland gene
expression with host gene expression for infestations with
uninfected ticks and for infestations with ticks infected with B.
bovis or B.bigemina
Characterize tick-host interactions and tick feeding and
developmental time for R. microplus and R. annulatus
infestation of white-tailed deer under controlled experimental
infestations
Determine the developmental periods and survivorship of
cattle ticks throughout the year, number of tick generations
per year under field conditions, and seasonal dynamics in
southern Texas and/or Northern Mexico
Determine if pathogen-free R. microplus and R. annulatus can
become infected by taking a blood meal from Babesia-
infected white-tailed deer
Diagnosis, treatment,
& prevention
Improve and make commercially available diagnostic assays to
rapidly detect Texas cattle fever and CFT
Improve existing diagnostic tools and develop new assays
to detect human babesiosis to improve early diagnosis,
better predict disease complications, and screen blood
donors for silent infection
Assess level of preparedness by federal and state regulatory
agencies and the national animal health laboratory network to
handle an outbreak of Texas cattle fever
Initiate interdisciplinary investigations to define current and
ecological and environmental factors associated with
changes in tick vector and Babesia distributions
Establish a surveillance program to assess prevalence of B.
bovis and B. bigemina in wildlife and cattle in the permanent
quarantine zone
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Page 6 of 11Table 1: Research needs for bovine and human babesioses by scientific and technological topic. (Continued)
Conduct field research with cattle as tracer species in similar
way as suggested for the use of other species as sentinels of
ecological health [52], to generate science-based information
for developing decision-support tools for the CFT eradication
program
Develop new technologies for CFT surveillance and detection
in cattle and wildlife
Develop risk assessment systems to evaluate tick dispersal in
wildlife species adjacent to infested premises vacated of cattle
Continue research to develop and test live attenuated and
recombinant vaccines for the control of babesiosis
Integrated
approaches for
sustainable CFT
eradication
Revisit sterile tick techniques. In the late 1980s, sterile tick
experiments were performed on St. Croix with R. annulatus ×
R. microplus tick hybrids (R. Davey, unpublished results). One
hundred and eighty million hybrid larvae were put in tea bags
in the field. When sterile larvae were dropped in the field, the
tick population decreased over 7 to 8 months, but then began
to increase again. The disadvantages of this method are the
difficulties for a laboratory to produce enough sterile larvae,
the immobility of ticks and acceptance by owners to put
more ticks on their animals. Alternative methods to produce
sterile ticks using RNA interference have been proposed [53].
However, this strategy has serious limitations relative to large-
scale field trials and practical application on broad
geographical areas. However, these new technologies coupled
with further observations on crosses between R. annulatus and
R. microplus and between some R. microplus geographical
strains that produce sterile ticks warrant further studies on the
potential use of the sterile tick technique for CFT eradication
[[54,55] and references thereof].
Not applicable
Continue and improve research on the mechanisms and
dynamics of tick genetic resistance to acaricides. Apply this
knowledge on the enhanced use of acaricides and acaride
combinations
Develop acaricide combinations. The combination of
acaricides and tick growth regulators offers the potential to
achieve the high levels of efficacy required for eradication.
These efforts need to be pursued despite current challenges
to seek and secure approval for registration by the regulatory
agencies. The use of novel application technologies like
electro-charged spray systems that could improve the spray/
dip process should be investigated
Investigate passive administration of systemic acaricides for
cattle. Mineral/protein blocks are commonly used in cattle
production systems. The use of a mineral/protein block
medicated with a systemic acaricide such as ivermectin could
be a useful tool for the eradication of CFT
Develop sustained acaricide delivery systems. When applicable
per eradication regulations, the practice of dipping cattle in a
vat with Coumaphos every 14 days is both a costly and
laborious effort. Thus, systems delivering acaricides in a
sustained fashion to achieve eradication efficacy levels for at
least 2 months are needed. This approach requires fine-tuning
of available formulations and sustained-release technologies to
address safety and withdrawal period issues to deliver a
registerable and marketable product accessible to the
producer. Microspheres and other sustained release
technologies have the potential to provide those solutions.
However, these formulations face the same commercial
barriers mentioned above for traditional acaricides. Business
models like the public-private partnership for product
development to treat neglected diseases requires
consideration as a strategy to achieve solutions for the Cattle
Fever Eradication Program involving proven technologies that
remain undeveloped and collecting dust on the shelf [56]
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Page 7 of 11resulting in death [43,45]. The majority of healthy adults
experience a mild to moderate illness. Immunocompro-
mised individuals are at the highest risk of severe dis-
ease, including those with malignancy, HIV infection,
absence of a spleen, use of immune-suppressive drug
therapy, and people over the age of 50 years. Asympto-
matic carriers present a considerable safety risk to the
blood supply and babesiosis is the most commonly
reported infectious agent transmitted by blood transfu-
sion in the U.S [46].
Ecology and biology of tick vectors and wildlife
As with CTF in Texas, the risk of human babesiosis in
the northern US in influenced by the distribution and
abundance of wildlife species. Rodent reservoirs of B.
mictori are ubiquitous, but enzootic transmission is only
known to occur in the presence of I. scapularis [47].
The primary cause for the emergence of human babe-
siosis is due to an increase in white-tailed deer popula-
tions in the Northeast and upper Midwest which host
t h ea d u l ts t a g eo fI. scapularis. Controlling tick infesta-
tions in white-tailed deer or elimination of the deer
population may sharply reduc et h er i s ko fb a b e s i o s i s
and other I. scapularis-borne infections such as Lyme
disease and human anaplasmosis. Like other tick-borne
disease systems where white-tailed deer are a keystone
host, deer-targeted tick control in the Northeast resulted
in an overall decrease in the human risk for exposure to
Borrelia burgdorferi and Anaplasma phagocytophilum
[48]. Additionally, a population of I. scapularis ticks was
eliminated after deer were removed from Monhegan
Island, Maine [49]. The local elimination of white-tailed
deer or methods for preventing I. scapularis from feed-
ing upon deer, such as acaricides or anti-tick vaccines,
seems to provide the most promising option for pre-
venting human babesiosis as well as other I. scapularis-
borne pathogens [47].
Diagnosis, treatment, and prevention
Diagnosis of human babesiosis depends on laboratory
testing techniques because symptoms are relatively non-
specific. Definitive diagnosis of Babesia infection is gen-
erally made by microscopic identification of the organ-
ism on thin blood smear, amplification of Babesia DNA
by PCR and detection of Babesia antibody by ELISA
[50]. Antimicrobial therapy consists of atovaquone and
azithromycin or clindamycin and quinine. Only two
standard antimicrobial combinations currently exist. The
combination of atovaquone and azithromycin is effective
and well tolerated and is the most commonly used anti-
biotic treatment of human babesiosis [51]. Rare clinical
resistance in a few immunocompromised hosts has been
described. The other combination of clyndamicin and
quinine is especially useful in treatment of severe Babe-
sia cases, but is often poorly tolerated. Some immuno-
compromised hosts do not clear infection for months or
Table 1: Research needs for bovine and human babesioses by scientific and technological topic. (Continued)
Research for natural products. Natural products like fungi and
botanicals although shown to be potential alternatives [57,58],
are not yet available and more research is needed before
these products can be considered and integrated into tick
control programs
Enhance exchange of information between regulatory
agencies, research institutions, and the public to facilitate the
development and implementation of evidence-based
regulations for the CFT eradication program addressing the
ecology of wildlife/cattle-tick-Babesia interactions
Increase efforts and collaborations with agricultural extension
systems to disseminate current knowledge and research
findings among producers and the public in the U.S. to raise
awareness of current national biosecurity threat involving CFT
and bovine babesiosis. Additionally, similar efforts need to be
established in Mexican states bordering the permanent
quarantine zone in Texas through collaboration with
colleagues in Mexico
Tick vaccines Compare the nucleotide sequences of Bm86 orthologs in U.S.
strains of R. microplus and R. annulatus with those of the
commercial Bm86 vaccines to determine whether antigen
sources need to be derived from geographic strains
Tick-vaccines and delivery methods for white-tailed deer to
prevent human babesiosis
Identify new tick protective antigens and delivery systems for
cattle and wildlife
Conduct studies to determine whether the treatment of cattle
with Gavac® or other Bm86-based vaccines in Mexico and the
U.S. permanent quarantine zone prevents CFT outbreaks in
Texas
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result in a mortality rate as high as 20% [45]. Exchange
transfusion may be life saving in severe cases. The use
of multiple prevention strategies is recommended and
consists of personal, residential and community
approaches [43].
Tick vaccines
Babesiosis vaccines have not been developed for
humans. Tick vaccines may help control of human
babesiosis by reducing the risk of pathogen transmission
from animals to humans after vaccination of animal
reservoir species.
See Table 1 for list of research needs in human
babesiosis.
Conclusions
Keeping CFT eradicated from the U.S. is a current and
critical agricultural biosecurity issue of national rele-
vance. Human babesiosis is an emerging disease of pub-
lic health concern in the U.S., especially for the
immunocompromised and people receiving blood trans-
fusions. The One Health approach to the discussion of
current issues on emerging babesioses during the work-
shop helped identify commonalities in research and
development initiatives that are critically important to
mitigate their impact on human and animal health. We
suggest that research be prioritized to these areas where
considerable gaps in knowledge and technology were
identified: 1) tick vector ecology studies addressing the
epidemiology of human and animal babesioses; 2) the
molecular basis of host-Babesia and host-tick interac-
tions in humans, livestock and wildlife; 3) implications
of the wildlife-livestock interface on the apparent resur-
gence of CFT outbreaks and the reservoir status of
white-tailed deer and non-native wild ungulates for B.
bovis and B. bigemina; 4) integrated approaches for sus-
tainable CFT eradication to include research on safer
acaricides with new modes of action and the develop-
ment of more effective formulations using active ingre-
dients already registered or approved with the
regulatory agencies; 5) diagnostic and prophylactic inter-
ventions for control of human and animal babesioses; 6)
assessing the utility of prophylactic intervention with
Bm86-based vaccines, or through the use of other tick
protective antigens, in CFT eradication efforts as well as
tick-vaccines and delivery methods for white-tailed deer
in human babesioisis prevention. Initiatives to pursue
the research needs presented here require adequate
funding, but the One Health concept offers the opportu-
nity to focus interdisciplinary research efforts that maxi-
mize the use of limited resources through collaborations
between investigators with expertise in the human and
veterinary medical sciences.
Acknowledgements
We thank Angie Heimann, Beth Lemeilleur, Barbara Pagel, Barbara Eastwood,
and Roger Sorenson for impeccable organizational support. Dr. Renato
Andreotti made helpful comments on the draft report. Melinda May
provided invaluable support to produce the graph. This paper is the results
of a workshop convened by the United States Department of Agriculture -
Agricultural Research Service and the Center for Ecoepidemiology, Yale
University School of Medicine on 22
nd and 23
rd of April 2009 in McAllen,
Texas. Other members of the Group for Emerging Babesioses and One
Health Research and Development in the U.S. are: Dr. Sandra A. Allan,
Mosquito and Fly Research Unit, Research Entomologist, 1600 - 1700 SW
23
rd Drive, Gainesville, FL 32608, (352) 374-5940 Sandy.Allan@ars.usda.gov;
Dr. José M. Ávila-Curiel, Ph.D., Researcher in Grazing Animal Nutrition, INIFAP
- SAGARPA, Francisco Mendoza No. 212, Col. Azuncion Avalos, Cd. Madero,
Tamaulipas, Mexico, CP 89416, (836) 276-0023/24; Cell: (833) 167-7158, Avila.
josemiguel@inifap.gob.mx; Dr. Richard Bishop, Senior Molecular Biologist,
International Livestock Research Institute (ILRI), P.O. Box 30709, GPO 00100,
Nairobi, Kenya, Tel: +254(0)20 4223000 (switchboard) 4223359 (office), r.
bishop@cgiar.org; Dr. Antonio Cantu, INIFAP - SAGARPA, Universidad
Autónoma, Tuxtla Gutiérrez, Chiapas, Mexico, Cantu.antonio@inifap.gob.mx;
Dr. James R. Coppedge, Associate Area Director, USDA-ARS-Southern Plains
Area, 1001 Holleman Drive East, College Station, TX 77840-4147, (979) 260-
9346, james.coppedge@ars.usda.gov; Mr. Lavoyger Durham, South Texans’
Property Rights Association, P.O. Box 397, Falfurrias, Texas 78355, (361) 522-
5194; Mrs. Susan Durham, South Texans’ Property Rights Association, P.O.
Box 397, Falfurrias, Texas 78355, (361) 522-5194, susan@stpra.org; Dr. Jim
Gallagher, Assistant Professor and Extension Wildlife Specialist, Wildlife and
Fisheries Science Dept., Texas AgriLife Extension Service, PO Box 1849, 1619
Garner Field Road, Uvalde, TX 78802-1849 830-278-9151, jfgallagher@ag.
tamu.edu; Dr. Patricia Holman, Research Assistant Professor, Department of
Veterinary Pathobiology, College of Veterinary Medicine and Biomedical
Sciences Texas A&M University College Station, TX 77843-4467, (979) 845-
4202, pholman@cvm.tamu.edu; Mr. Larry Jung, Assistant Director Field
Operations, Cattle Fever Tick Eradication Program, P.O. Box 567, Del Rio,
Texas 78841, Phone # 830-775-5452, Larry.D.Jung@usda.gov; Dr. James B.
Lenarduzzi, Area 5 Director, Animal Health Commission, 3811 N. Saint Marys
St, Beeville, Texas 78102-2128, (361) 358-3234, jamesl@tahc.state.tx.us; Dr.
Byron E. Rippke, Director, Policy, Evaluation & Licensing, USDA Center for
Veterinary Biologics, 1920 Dayton Road, Ames, IA 50010, (515) 337-6101,
Byron.E.Rippke@aphis.usda.gov; Mr. Sam Rodriquez, R Y Livestock Sales, Rio
Grande City, Texas, cattlemansam@aol.com; Mr. Fausto Salinas Jr., F&M Farms
& Cattle Company, Salinasfaust@gmail.com; Dr. Greta Schuster, Texas A & M
University, Associate Professor - Agronomist, Department of Agronomy &
Resource Sciences, MSC 228 Kleberg AG Bldg. RM 116, Kingsville, Texas
78363-8202, (361) 593-4116, kugs2002@tamuk.edu.
Author details
1Knipling-Bushland U.S. Livestock Insects Research Laboratory, USDA-ARS,
Kerrville, TX, USA.
2National Program, Animal Production and Protection,
USDA-ARS, Beltsville, MD, USA.
3Animal Disease Research Unit, U.S.
Department of Agriculture/Agriculture Research Service, Pullman, WA 99164-
7030, USA.
4Department of Epidemiology and Public Health, Yale School of
Medicine, New Haven, CT 06520, USA.
5Department of Veterinary
Pathobiology, Center for Veterinary Health Sciences, Oklahoma State
University, Stillwater, OK 74078, USA.
6Instituto de Investigación en Recursos
Cinegéticos IREC (CSIC-UCLM-JCCM), Ronda de Toledo s/n, 13005 Ciudad
Real, Spain.
7Division of Epidemiology of Microbial Diseases, Yale School of
Public Health, New Haven, CT 06520-8034, USA.
8Department of Pathology,
University of Texas Medical Branch, Galveston, TX 77555, USA.
9USDA-APHIS,
2150 Centre Ave, Bldg. B-2W4, Fort Collins, Colorado 80526, USA.
10Department of Veterinary Pathobiology, College of Veterinary Medicine,
University Drive and Agronomy Road, Texas A&M University, College Station,
TX 77843, USA.
11Facultad de Medicina Veterinaria y Zootecnia, Universidad
Autónoma de Tamaulipas, Km. 5 carretera Victoria-Mante, CP 87000 Ciudad
Victoria, Tamaulipas, Mexico.
12Texas Animal Health Commission, Austin, TX
78758-4013, USA.
13Cattle Fever Tick Eradication Program, USDA-APHIS-VS,
Riverdale, MD 20737, USA.
14USDA-APHIS-VS, Thornberry Bldg., Rm. 220 903
San Jacinto Blvd. Austin, TX 78701, USA.
15Cattle Fever Tick Eradication
Program, USDA-APHIS-VS, San Juan, TX 78589, USA.
16Department of
Entomology, Texas A&M University, College Station 77843, USA.
17Animal &
Wildlife Sciences, Texas A&M University, 700 University Blvd., Kingsville, Texas
Pérez de León et al. Parasites & Vectors 2010, 3:36
http://www.parasitesandvectors.com/content/3/1/36
Page 9 of 1178363, USA.
18Cattle Fever Tick Eradication Program, USDA-APHIS-VS, Laredo,
TX 78040, USA.
19Animal Disease Research Unit, Agricultural Research Service,
United State Department of Agriculture, Pullman, WA 99164-6630, USA.
20Program in Vector-Borne Diseases, Department of Veterinary Microbiology
and Pathology, Washington State University, Pullman, WA 99164-7040, USA.
21Animal Diseases Research Unit, Agricultural Research Service, U.S.
Department of Agriculture, Pullman, Washington 99164, USA.
Authors’ contributions
All coauthors in the paper contributed to drafting the manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 6 February 2010 Accepted: 8 April 2010
Published: 8 April 2010
References
1. Hunfeld KP, Hildebrandt A, Gray JS: Babesiosis: recent insights into an
ancient disease. Int J Parasitol 2008, 38:1219-1237.
2. Chauvin A, Moreau C, Bonnet S, Plantard O, Malandrin L: Babesia and its
hosts: adaptation to long-lasting interactions as a way to achieve
efficient transmission. Vet Res 2009, 40:37.
3. de la Fuente J, Estrada-Peña A, Venzal JM, Kocan KM, Sonenshine DE:
Overview: Ticks as vectors of pathogens that cause disease in humans
and animals. Front Biosc 2008, 13:6938-6946.
4. George JE: The effects of global change on the threat of exotic
arthropods and arthropod-borne pathogens to livestock in the United
States. Ann NY Acad Sci 2008, 1149:249-254.
5. Kaplan B, Kahn LH, Monath TP, Woodall J: Health and parasitology.
Parasites & Vectors 2009, 2:36-38.
6. Peter RJ, Bossche Van den P, Penzhorn BL, Sharp B: Tick, fly, and mosquito
control-Lessons from the past, solutions for the future. Vet Parasitol 2005,
132:205-215.
7. Jonsson NN, Bock RE, Jorgensen WK: Productivity and health effects of
anaplasmosis and babesiosis on Bos indicus cattle and their crosses, and
the effects of differing intensity of tick control in Australia. Vet Parasitol
2008, 155:1-9.
8. Bram RA, George JE, Reichard RE, Tabachnick WJ: Threat of foreign
arthropod-borne pathogens to livestock in the United States. JM e d
Entomol 2002, 39:405-416.
9. Estrada-Peña A, Naranjo V, Acevedo-Whitehouse K, Mangold AJ, Kocan KM,
de la Fuente J: Phylogeographic analysis reveals association of tick-borne
pathogen, Anaplasma marginale, MSP1a sequences with ecological traits
affecting tick vector performance. BMC Biol 2009, 7:57.
10. Shillinger JE: Deer in relation to fever tick eradication in Florida. Trans N
Amer Wildl Conf 1938, 3:882-885.
11. Bram RA, George JE: Introduction of nonindigenous arthropod pests of
animals. J Med Entomol 2000, 37:1-8.
12. Owen IL: Rusa deer (Cervus timorensis) as a host for the cattle tick
(Boophilus microplus) in Papua New Guinea. J Wildl Dis 1977, 13:208-217.
13. Cooksey LM, Davey RB, Ahrens EH, George JE: Suitability of white-tailed
deer as hosts for cattle fever ticks (Acari: Ixodidae). J Med Entomol 1989,
26:155-158.
14. Davey RB: Stagewise mortality, ovipositional biology, and egg viability of
Boophilus annulatus (Acari: Ixodidae) on Boselaphus tragocamelus
(Artiodactyla: Bovidae). J Med Entomol 1993, 30:997-1002.
15. Szabó MP, Labruna MB, Pereira MC, Duarte JM: Ticks (Acari: Ixodidae) on
wild marsh-deer (Blastocerus dichotomus) from Southeast Brazil:
infestations before and after habitat loss. J Med Entomol 2003, 40:268-274.
16. Cantu A, Ortega-S JA, Mosqueda J, Garcia-Vazquez Z, Henke SE, George JE:
Immunologic and molecular identification of Babesia bovis and Babesia
bigemina in free-ranging white-tailed deer in northern Mexico. J Wildl Dis
2007, 43:504-507.
17. Cantu A, Ortega-S JA, García-Vázquez Z, Mosqueda J, Henke SE, George JE:
Epizootiology of Babesia bovis and Babesia bigemina in free-ranging
white-tailed deer in northeastern Mexico. J Parasitol 2009, 95:536-542.
18. Traweek MS: Statewide census of exotic big game animals. Texas Parks
and Wildlife Department, Federal Aid Project W-109 1995, job no 21.
19. Gray GG, Simpson CD: Ammotragus lervia. Mammalian Species 1980,
144:1-7.
20. Mungall EC: Exotics. Ecology and Management of Large Mammals in North
America Upper Saddle River, NJ, USA: Prentice Hall IncDemarais S, Krausman
PR 2000, 658-693.
21. Mungall EC: Exotic Animal Field Guide. Nonnative Hoofed Mammals in the
United States College Station, TX, USA: A&M University Press 2007, 585-586.
22. Teer JG: Wildlife production: conservation and sustainable development.
Non-native large ungulates in North America Fairbanks: Univ. Alaska Agric.
For Exp Stn Misc Publ 91-6Renecker LA, Hudson RJ 1991, 55-66.
23. Witmer GW, Lewis JC: Introduced wildlife of Oregon and Washington.
Wildlife-habitat relationships in Oregon and Washington Corvallis, OR, USA:
Oregon State University PressJohnson D, O’Neil T 2001, 423-443.
24. Chapman N: The distribution of the fallow deer: a worldwide review.
Mammal Review 1980, 10:2-3.
25. Feldhammer GA, Farris-Renner KC, Barker CM: Dama dama. Mammalian
Species 1988, 317:1-8.
26. Leslie DM: Boselaphus tragocamelus (Artiodactyla: Bovidae). Mammalian
Species 2008, 813:1-16.
27. Baviskar B, Ingle K, Gawande P, Raut S, Sirothia K, Bhandarkar A: First report
on occurrence of Babesia infection in nilgai Boselaphus tragocamelus
from central India. Threatened Taxa 2009, 1:196.
28. Carvalho WA, Franzin AM, Rodriguez Abatepaulo AR, Freire de Oliveira CJ,
Dantas Moré D, Santana da Silva J, Rossetti Ferreira B, Miranda Santos I:
Modulation of cutaneous inflammation induced by ticks in contrasting
phenotypes of infestation in bovines. Vet Parasitol 2010, 167:260-73.
29. Piper EK, Jackson LA, Bielefeldt-Ohmann H, Gondro C, Lew-Tabor AE,
Jonsson N: Tick-susceptible Bos taurus cattle display an increased cellular
response at the site of larval Rhipicephalus (Boophilus) microplus
attachment, compared with tick-resistant Bos indicus cattle. Int J Parasitol
2010, 40:431-441.
30. Goff WL, Molloy JB, Johnson WC, Suarez CE, Pino I, Rhalem A, Sahibi H,
Ceci L, Carelli G, Adams DS, McGuire TC, Knowles DP, McElwain TF:
Validation of a competitive enzyme-linked immunosorbent assay for
detection of antibodies against Babesia bovis. Clin Vaccine Immunol 2006,
13:1212-1216.
31. Goff WL, Molloy JB, Johnson WC, Suarez C, Pino I, Rhalem A, Sahibi H,
Ceci L, Carelli G, Scott Adams D, McGuire TC, Knowles DP, McElwain TF:
Validation of a competitive enzyme-linked immunosorbent assay for
detection of Babesia bigemina antibodies in cattle. Clin Vaccine Immunol
2008, 15:1316-1321.
32. Alarcon-Chaidez F, Ryan R, Wikel S, Dardick K, Lawler C, Foppa IM, Tomas P,
Cushman A, Hsieh A, Spielman A, Bouchard KR, Dias F, Aslanzadeh J,
Krause PJ: Confirmation of tick bite by detection of antibody to Ixodes
calreticulin salivary protein. Clin Vaccine Immunol 2006, 13:1217-1222.
33. Suarez CE, McElwain TF: Transfection systems for Babesia bovis: a review
of methods for the transient and stable expression of exogenous genes.
Vet Parasitol 2010, 167:205-215.
34. Brayton KA, Lau AO, Herndon DR, Hannick L, Kappmeyer LS, Berens SJ,
Bidwell SL, Brown WC, Crabtree J, Fadrosh D, Feldblum T, Forberger HA,
Haas BJ, Howell JM, Khouri H, Koo H, Mann DJ, Norimine J, Paulsen IT,
Radune D, Ren Q, Smith RK Jr, Suarez CE, White O, Wortman JR,
Knowles DP Jr, McElwain TF, Nene VM: Genome sequence of Babesia bovis
and comparative analysis of apicomplexan hemoprotozoa. PLoS Pathog
2007, 3:1401-1413.
35. Brown WC, Norimine J, Goff WL, Suarez CE, McElwain TF: Prospects for
recombinant vaccines against Babesia bovis and related parasites.
Parasite Immunol 2006, 28:315-327.
36. Malone JB: Texas fever, two-headed calves and the Hatch Act – 100
years and counting for veterinary parasitology in the United States. Vet
Parasitol 1989, 33:3-29.
37. Dolman CE: Texas cattle fever: A commemorative tribute to Theobald
Smith. Clio Medica 1969, 4:1-31.
38. Ojan A, Stanek G: Theobald Smith - the discoverer of ticks as vectors of
disease. Wien Ken Wochenschr 2002, 114:479-48l.
39. de la Fuente J, Almazán C, Canales M, Pérez de la Lastra JM, Kocan KM,
Willadsen P: A ten-year review of commercial vaccine performance for
control of tick infestations on cattle. Anim Health Res Rev 2007, 8:23-28.
40. Graf JF, Gogolewski R, Leach-Bing N, Sabatini GA, Molento MB, Bordin EL,
Arantes GJ: Tick control: an industry point of view. Parasitol 2004, 129:
S427-S442.
41. Willadsen P: Tick control: thoughts on a research agenda. Vet Parasitol
2006, 138:161-168.
Pérez de León et al. Parasites & Vectors 2010, 3:36
http://www.parasitesandvectors.com/content/3/1/36
Page 10 of 1142. Sonenshine DE, Kocan KM, de la Fuente J: Tick control: further thoughts
on a research agenda. Trends Parasitol 2006, 22:550-551.
43. Vannier E, Krause P: Update on babesiosis. Interdiscip Perspect Infect Dis
2009, 2009:984568.
44. Young C, Krause PJ: The problem of transfusion-transmitted babesiosis.
Transfusion 2009, 49:2548-2550.
45. Krause PJ, Gewurz BE, Hill D, Marty FM, Vannier E, Foppa IM, Furman RR,
Neuhaus E, Skowron G, Gupta S, McCalla C, Pesanti EL, Young M, Heiman D,
Hsue G, Gelfand JA, Wormser GP, Dickason J, Bia FJ, Hartman B, Telford SR,
Christianson D, Dardick K, Coleman M, Girotto JE, Spielman A: Persistent
and relapsing babesiosis in immunocompromised patients. Clin Infect Dis
2008, 46:370-376.
46. Gubernot DM, Lucey CT, Lee KC, Conley GB, Holness LG, Wise RP: Babesia
infection through blood transfusions: reports received by the US Food
and Drug Administration, 1997-2007. Clin Infect Dis 2009, 48:25-30.
47. Fish D, Childs JE: Community-based prevention of Lyme disease through
topical application of acaricides to white-tailed deer: background and
rationale. Vector Borne Zoonot Dis 2009, 9:357-364.
48. Gatewood Hoen A, Rollend LG, Papero MA, Carroll JF, Daniels TJ,
Mather TN, Schulze TL, Stafford KC, Fish D: Effects of tick control by
acaricide self-treatment of white-tailed deer on host-seeking tick
infection prevalence and entomological risk for Ixodes scapularis-borne
pathogens. Vector Borne Zoonot Dis 2009, 9:431-438.
49. Rand PW, Lubelczyk C, Holman MS, Lacombe EH, Smith RP: Abundance of
Ixodes scapularis (Acari: Ixodidae) after the complete removal of deer
from an isolated offshore island, endemic for Lyme disease. JM e d
Entomol 2004, 41:779-784.
50. Krause PJ, McKay K, Thompson CA, Sikand VK, Lentz R, Lepore T, Closter L,
Christianson D, Telford SR, Persing D, Radolf JD, Spielman A, Deer-
Associated Infection Study Group: Disease-specific diagnosis of
coinfecting tickborne zoonoses: babesiosis, human granulocytic
ehrlichiosis, and Lyme disease. Clin Infect Dis 2002, 34:1184-1191.
51. Krause PJ, Lepore T, Sikand VK, Gadbaw J Jr, Burke G, Telford SR, Brassard P,
Pearl D, Azlanzadeh J, Christianson D, McGrath D, Spielman A: Atovaquone
and azithromycin for the treatment of babesiosis. N Engl J Med 2000,
343:1454-1458.
52. Alonso Aguirre A: Wild canids as sentinels of ecological health: a
conservation medicine perspective. Parasites & Vectors 2009, 2:S1-S7.
53. de la Fuente J, Almazán C, Naranjo V, Blouin EF, Meyer JM, Kocan KM:
Autocidal control of ticks by silencing of a single gene by RNA
interference. Biochem Biophys Res Commun 2006, 344:332-338.
54. Spickett AM, Malan AR: Genetic incompatibility between Boophilus
decoloratus (Koch 1844) and Boophilus microplus (Canestrini, 1888) and
hybrid sterility of Australian and South African Boophilus microplus
(Acarina: Ixodidae). Onderstepoort J Vet Res 1978, 45:149-153.
55. Labruna MB, Naranjo V, Mangold AJ, Thompson C, Estrada-Peña A,
Guglielmone AA, Jongejan F, de la Fuente J: Allopatric speciation in ticks:
genetic and reproductive divergence between geographic strains of
Rhipicephalus (Boophilus) microplus. BMC Evol Biol 2009, 9:46.
56. Chatelain E, Don R: Antiparasitic Antibacterial Drug Discovery. Drug
discovery for neglected diseases: View of a public-private partnership Wiley-
BlackwellSelzer PM 2009.
57. Bagavan A, Kamaraj C, Elango G, Zahir AA, Rahuman AA: Adulticidal and
larvicidal efficacy of some medicinal plant extracts against tick, fluke
and mosquitoes. Vet Parasitol 2009, 166:286-292.
58. Polar P, Moore D, Kairo MT, Ramsubhag A: Topically applied myco-
acaricides for the control of cattle ticks: overcoming the challenges. Exp
Appl Acarol 2008, 46:119-148.
59. Pelzel A: The United States Department of Agriculture, Animal and Plant
Health Inspection Service. 2005 [http://www.aphis.usda.gov/vs/ceah/ncahs/
nsu/outlook/issue7/cattle_fever_tick_surveillance.pdf].
doi:10.1186/1756-3305-3-36
Cite this article as: Pérez de León et al.: One Health approach to
identify research needs in bovine and human babesioses: workshop
report. Parasites & Vectors 2010 3:36.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Pérez de León et al. Parasites & Vectors 2010, 3:36
http://www.parasitesandvectors.com/content/3/1/36
Page 11 of 11